EURETINA
In this Expert Pearl, Prof. Andrzej Grzybowski explores why cataract surgery in high myopia should be approached as more than a routine procedure. From complex biometry and IOL selection to retinal risk and patient expectations, he outlines the key considerations needed to optimise outcomes in this challenging patient population.
At EURETINA 2025 in Paris, Dr David Eichenbaum presented late-breaking data on the use of structural biomarkers to predict exudative AMD in geographic atrophy (GA). Using real-world datasets and AI-powered analysis via the EvidenceEngine platform, his research demonstrates how multimodal imaging and validated biomarkers can deliver rapid, scalable insights into disease progression. In this Q&A, Dr Eichenbaum shares his perspectives on: How AI-based approaches compare with traditional clinical trial methods The key biomarkers linked to increased exudation risk in GA The potential for AI-driven biomarker research to transform retinal disease management and future clinical research
Intraocular lenses (IOLs) are central to restoring vision after cataract surgery, but selecting the right lens in complex eyes requires precision, experience and the correct tools. In this Q&A, Professor Andrzej Grzybowski shares his expert practice pearls on achieving the best possible refractive outcomes in challenging cases.
In this Q&A, he shares insights into his career, research interests and the evolving landscape of ophthalmic care.
As 2024 draws to a close, we’re celebrating a remarkable year of content.
The EURETINA 2024 Congress, held in Barcelona from September 19-22, brought together leading experts in ophthalmology to share the latest research and innovative treatments for retinal diseases. Among the highlights were several late-breaking abstracts that showcased promising advances in therapeutics for conditions such as retinopathy of prematurity (ROP), diabetic retinopathy (DR) and age-related macular degeneration (AMD). These studies not only demonstrated the efficacy and safety of novel treatment options but also addressed critical unmet needs in reducing patient burden and improving long-term outcomes.
It was a pleasure to talk to Roxane Hillier (Newcastle Eye Centre, Newcastle, UK) on her EURETINA course on rhegmatogenous retinal detachment repair. In this interview, she discussed the treatment options for rhegmatogenous retinal detachment. The instructional course entitled “Mechanisms ...
In this touchOPHTHALMOLOGY interview, Roxane Hillier (Newcastle Eye Centre, Newcastle, UK) discussed techniques involved in retinal reattachment and shared the highlights from her EURETINA course on rhegmatogenous retinal detachment repair. The instructional course entitled “Mechanisms of Action in Rhegmatogenous Retinal ...
In this touchOPHTHALMOLOGY interview, Prof. Francesco Bandello (Department of Ophthalmology University Vita-Salute Scientific Institute San Raffaele, Milan, Italy) talks us through the advantages of optical coherence tomography angiography (OCTA) over conventional dye angiography in age-related macular degeneration (AMD) and a ...
In this touchOPHTHALMOLOGY interview, Prof. Francesco Bandello (Department of Ophthalmology University Vita-Salute Scientific Institute San Raffaele, Milan, Italy) discussed the findings of a study investigating the relationship between optical coherence tomography angiography and fluorescein angiography/indocyanine green angiography in AMD ...
In this touchOPHTHALMOLOGY interview, Prof. Gemmy Cheung (Duke-NUS Medical School, National University of Singapore, Singapore) discussed how the imaging techniques that have been used for the classification and diagnosis of central serous chorioretinopathy have been changing. ‘New imaging insights in ...
In this touchOPHTHALMOLOGY interview, Prof. Gemmy Cheung (Duke-NUS Medical School, National University of Singapore, Singapore) talks us through central serous chorioretinopathy and the imaging techniques that have been used for its classification and diagnosis. ‘New imaging insights in CSC’ was ...
Prof. Bart Leroy (Ghent University, Ghent, Belgium) joined touchOPHTHALMOLOGY in an interview to speak about RNA interference therapy and its advantages in treating inherited retinal diseases caused by CEP290 mutations. ‘RNA Interference Therapy for CEP290-IRD’ was presented at EURETINA 2022, 1–4 ...
The Archway study (NCT03677934) was a phase 3, randomized, active treatment–controlled trial for the treatment of nAMD, conducted at 77 study locations in the United States. We caught up with Prof. Usha Chakravarthy (Queen's University of Belfast, Belfast, Northern Ireland) to ...
It was great to catch up with Prof. Jakob Grauslund (Odense University Hospital, Odense, Denmark) to discuss the advantages of navigated laser photocoagulation systems and their advantages over traditional retinal laser for the treatment of diabetic macular oedema and proliferative ...
In this interview on her EURETINA presentation, Prof. Kyoko Ohno-Matsui (Tokyo Medical and Dental University, Tokyo, Japan) discussed choroidal venous structures and how they change in myopic eyes. ‘Anomalies of choroidal venous structures in high myopia’ was presented at EURETINA 2022, 1–4 ...
touchOPHTHALMOLOGY
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
